G1 Therapeutics Inc.

NASDAQ: GTHX · Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM

G1 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
32.28M 94.59M 221.19M
Short-Term Investments
49.94M 50.48M n/a
Long-Term Investments
187K 250K 312K
Other Long-Term Assets
21K 264K 1.17M
Receivables
12.69M 11.09M 5.69M
Inventory
12.44M 16.18M 3.47M
Other Current Assets
7.66M 7.16M 63K
Total Current Assets
114.95M 179.5M 243.56M
Property-Plant & Equipment
6.38M 7.95M 9.05M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
6.59M 8.46M 10.53M
Total Assets
121.54M 187.97M 254.09M
Account Payables
3.99M 7.43M 2.9M
Deferred Revenue
620K 7K 31K
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
8.2M 6.88M 5.16M
Total Current Liabilities
29.72M 35.59M 27.61M
Long-Term Debt
51.56M 77.02M 75.19M
Other Long-Term Liabilities
41K n/a n/a
Total Long-Term Liabilities
56.44M 83.63M 82.94M
Total Liabilities
86.15M 119.22M 110.55M
Total Debt
57.17M 83.77M 83.06M
Common Stock
5K 5K 4K
Retained Earnings
-779.99M -732.02M -584.46M
Comprehensive Income
-0.00 -0.00 -0.00
Shareholders Equity
35.39M 68.75M -584.46M
Total Investments
50.13M 50.48M 312K